Home Compare JAZZ vs VTRS
Stock Comparison · Valuation-led comparison

Jazz Pharmaceuticals vs Viatris: Which Stock Looks Stronger in 2026?

Viatris holds the cleaner structural position, with valuation as the main driver and stability adding further support. Jazz Pharmaceuticals still has the edge on growth, which keeps the comparison from looking entirely one-sided. The market setup is broadly comparable for both — no clear directional signal from price behavior. The market is not adding a decisive signal either way — the structural read carries the weight.

The comparison is based on similar long-term financial trajectories, not sector labels. Both peer scores are relative to the Russell 1000 universe, making them directly comparable.

Updated 2026-05-17

The comparison is mainly decided in valuation, with the rest of the profile carrying less weight. The overall score gap is 23 points in favour of Viatris Inc..

Trajectory Similarity
0.65
Moderately similar
Peer-set rank: #11
within Jazz Pharmaceuticals plc's functional peer set

This comparison is anchored in long-term financial trajectory similarity within the selected peer universe.

A moderate similarity means the pair is structurally comparable, but not a near-twin trajectory match.

The strongest overlap appears in investment intensity and revenue stability.

Similarity drivers
investment intensityrevenue stability
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
JAZZ
Jazz Pharmaceuticals plc
42
Peer-Score
Signal qualitylow
Peer basis: Russell 1000
vs
VTRS
Viatris Inc.
65
Peer-Score
Signal qualitylow
Peer basis: Russell 1000

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

Pricing shapes this comparison more than a broad operating gap.

Dimension spread: JAZZ vs VTRS Profitability 34 29 Stability 49 70 Valuation 8 86 Growth 100 80 JAZZ VTRS
Gap Ranking
#1 Valuation +78
#2 Stability +21
#3 Growth +20
#4 Profitability +5
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for JAZZ and VTRS Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer JAZZVTRS Relative valuation Structural strength

The structural gap is limited here, but current pricing still leans against Jazz Pharmaceuticals plc.

Valuation position uses peer-relative PE percentile (idx_pct_pe) and Forward P/E where available.

Entry today — historical context

Where JAZZ and VTRS each sit in their own 5-year price and valuation history.

BASED ON 5-YEAR HISTORY JAZZ Elevated · above norm 0th 50th 100th 0 pct gap VTRS Elevated · above norm 0th 50th 100th 99th 99th
JAZZ (99th percentile) and VTRS (99th percentile) both sit in the upper portion of their own 5-year ranges. The historical entry context is broadly similar for both. This reflects entry timing, not which company is structurally stronger.

Describes historical entry positioning only. Descriptive — not investment advice.

Relative Position vs Comparable Companies
Valuation
On valuation, Viatris Inc. ranks near the top of the group; Jazz Pharmaceuticals plc sits in the weaker half.
Stability
On stability, the same pattern holds: both are strong, but Viatris Inc. still leads clearly.
Valuation — Dominant Gap
JAZZ
8
VTRS
86
Gap+78in favour of VTRS

The multiple-based pricing edge comes from a forward P/E that is 2.8 turns lower.

What else supports the lead

Trajectory data does not fully confirm the current gap, which keeps conviction below a fully established read.

What this means for the comparison

Valuation is the clearest driver of the lead, with stability adding further support — though growth still provides a real counterweight.

Explore full peer positioning in AssetNext

Break down the JAZZ vs VTRS comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Other comparisons with conflicting dimension signals

Explore how JAZZ and VTRS each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.